Published in Ann Dermatol Venereol on October 01, 2001
Evidence for a pharmacogenetic adapted dose of oral anticoagulant in routine medical practice. Eur J Clin Pharmacol (2008) 0.82
Fluindione-induced immuno-allergic interstitial nephritis. NDT Plus (2008) 0.75
Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect? Eur J Clin Pharmacol (2011) 0.75
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet (1998) 4.72
A test of the nature of cosmic acceleration using galaxy redshift distortions. Nature (2008) 2.65
Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol (1995) 2.37
Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) (2000) 2.35
Heterogeneous bullous pemphigoid antibodies: detection and characterization by immunoblotting when absent by indirect immunofluorescence. J Invest Dermatol (1989) 2.25
Leg ulcers and hydroxyurea: forty-one cases. Arch Dermatol (1999) 1.77
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. J Viral Hepat (2005) 1.64
Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. Arthritis Rheum (2004) 1.63
Refractory polymyositis responding to infliximab: extended follow-up. Rheumatology (Oxford) (2004) 1.56
Thymoma-associated pancytopenia: effectiveness of cyclosporine A. Ann Hematol (1998) 1.47
[Bordetella bronchiseptica in a patient with prostatic adenocarcinoma]. Enferm Infecc Microbiol Clin (1997) 1.41
[A history of diseases: apropos of idiopathic capillary hyperpermeability syndrome]. Presse Med (1999) 1.40
Role of drug exposure in aphthous ulcers: a case-control study. Br J Dermatol (2000) 1.39
[Rheumatoid hyperthyroidism. Another observation]. Presse Med (1999) 1.39
Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique. Arch Dermatol (1989) 1.21
Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides. Br J Rheumatol (1997) 1.20
Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med (2001) 1.19
Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev (2010) 1.19
Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum Reprod (2001) 1.19
Bier's white spots associated with scleroderma renal crisis. Clin Exp Dermatol (2006) 1.17
The late results of caval ligation. Surgery (1970) 1.14
[Lymphoma with bilateral orbital tumors]. Med Clin (Barc) (1991) 1.07
Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod (2000) 1.06
[Historic malignant tumour: 27 observations]. Ann Dermatol Venereol (2011) 1.06
Abnormal synaptic protein expression and cell death in murine scrapie. Acta Neuropathol (2002) 1.04
Prevalence and characteristics of Sjögren's syndrome or Sicca syndrome in chronic hepatitis C virus infection: a prospective study. J Rheumatol (2001) 1.04
Drugs acting as plasticizers in polymeric systems: a quantitative treatment. J Control Release (2006) 1.04
[Disease associations in 250 patients with temporal (giant cell) arteritis]. Presse Med (2004) 1.02
Aortic angiosarcoma clinically mimicking polyarteritis nodosa. Scand J Rheumatol (2006) 1.02
Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J Invest Dermatol (1997) 0.99
Dermatomyositis and malignancy. J Invest Dermatol (1993) 0.98
[Giant buccal aphthosis caused by nicorandil]. Presse Med (1997) 0.96
Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis. Arch Dermatol (1990) 0.96
Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions. Br J Dermatol (2004) 0.96
Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab (2001) 0.96
The duration of the effects of a single administration of dopamine antagonists on ambulatory activity and motor coordination. J Neural Transm (Vienna) (1999) 0.96
Real-time PCR quantitation of hepatitis B virus total DNA and covalently closed circular DNA in peripheral blood mononuclear cells from hepatitis B virus-infected patients. J Virol Methods (2006) 0.95
Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases. Rheumatology (Oxford) (2000) 0.94
[Anticytoplasmic antibodies of human epidermal cells (author's transl)]. Ann Dermatol Venereol (1977) 0.93
Melorheostosis with associated minimal change nephrotic syndrome, mesenteric fibromatosis and capillary haemangiomas. Dermatology (1994) 0.93
Genetic and epigenetic changes in mammary epithelial cells identify a subpopulation of cells involved in early carcinogenesis. Cold Spring Harb Symp Quant Biol (2005) 0.91
Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: a retrospective, longitudinal survey (MELODY study). Eur J Cancer (2012) 0.91
Association between the inflammatory response and the risk of developing irreversible cranial ischemic complications: comment on the article by Cid et al and the letter by Nesher and Sonnenblick. Arthritis Rheum (1999) 0.91
Mycophenolic acid plasma concentrations: influence of comedication. Ther Drug Monit (2001) 0.91
Oral nicorandil-induced lesions are not aphthous ulcers. J Oral Pathol Med (2003) 0.91
Is naïveté forever? Alien predator and aggressor recognition by two endemic island reptiles. Naturwissenschaften (2014) 0.91
Neuropletic malignant syndrome and olanzapine. J Clin Psychopharmacol (2000) 0.90
Rhizomelic chondrodysplasia punctata type 1: report of mutations in 3 children from India. J Appl Genet (2010) 0.90
The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita. J Invest Dermatol (1991) 0.89
Interstitial cells of Cajal and neuromuscular transmission in the rat lower oesophageal sphincter. Neurogastroenterol Motil (2007) 0.89
[Vasculitis assessment with [18F]FDG positron emission tomography]. Rev Med Interne (2010) 0.89
[Vitiligo in multiple autoimmune syndrome: a retrospective study of 11 cases and a review of the literature]. Rev Med Interne (1998) 0.89
[Evolution of Sjögren syndrome associated with hepatitis C virus when chronic hepatitis C is treated by interferon or the association of interferon and ribavirin]. Rev Med Interne (2005) 0.89
Skin antibodies in bone marrow transplanted patients. Clin Exp Dermatol (1976) 0.88
[Bacterial dermo-hypodermatitis in adults. Incidence and role of streptococcal etiology]. Ann Dermatol Venereol (1995) 0.88
Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study). Eur J Cancer (2012) 0.88
Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome. Scand J Rheumatol (2009) 0.88
[Immunofluorescence in temporal arteritis]. N Engl J Med (1978) 0.87
Priorities for cancer control in Spain. Ann Oncol (2010) 0.87
Cervicofacial hemangioma and a minor sternal malformation: inclusion in PHACES syndrome? Pediatr Dermatol (1998) 0.85
[Diabetes insipidus revealing primary malignant non-Hodgkin's lymphoma of bone]. Rev Med Interne (1998) 0.85
Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: implications for implantation potential. J Assist Reprod Genet (2000) 0.85
Treatment of verrucous carcinoma with recombinant alfa-interferon. Dermatology (1995) 0.85
Cancer mortality trends in Spain: 1980-2007. Ann Oncol (2010) 0.85
High prevalence and risk factors of thromboembolism in stage IV melanoma. J Eur Acad Dermatol Venereol (2011) 0.84
Acquired ichthyosis and pyoderma gangrenosum in a patient with systemic lupus erythematosus. Clin Exp Dermatol (1993) 0.84
Comparison of IVF cycles reported in a voluntary ART registry with a mandatory registry in Spain. Hum Reprod (2010) 0.84
[Horton's disease revealed by brachial C5 plexopathy]. Rev Med Interne (2005) 0.84
Postoperative interstitial radiotherapy of keloids by iridium 192: a retrospective study of 46 treated scars. Dermatology (1997) 0.83
Fluorescent monitoring of kinase activity in real time: development of a robust fluorescence-based assay for Abl tyrosine kinase activity. Bioorg Med Chem Lett (2001) 0.83
[Physiopathology of bullous pemphigoid]. Ann Dermatol Venereol (2009) 0.83
Urticarial vasculitis induced by fluoxetine. Dermatology (1995) 0.83
Familial aquagenic urticaria. Dermatologica (1979) 0.83
[Methi-resistant Staphylococcus aureus in dermatological practice: origin, risk factors and outcome]. Ann Dermatol Venereol (2002) 0.83
[Drug-induced hypersensitivity syndrome in internal medicine: diagnostic and therapeutic traps. Eight observations]. Rev Med Interne (2000) 0.82
Granulomatous dermatitis after implantation of a titanium-containing pacemaker. Contact Dermatitis (1995) 0.82